| Literature DB >> 34046630 |
Henni-Karoliina Ropponen1,2, Eleonora Diamanti1, Alexandra Siemens3, Boris Illarionov3, Jörg Haupenthal1, Markus Fischer3, Matthias Rottmann4,5, Matthias Witschel6, Anna K H Hirsch1,2.
Abstract
In the search for new antibacterial compounds, we repositioned an antimalarial compound class by derivatising it based on the so-called "eNTRy" rules for enhanced accumulation into Gram-negative bacteria. We designed, synthesised and evaluated a small library of amino acid modified compounds together with the respective Boc-protected analogues, leading to no substantial improvement in antibacterial activity against Escherichia coli wild-type K12, whereas more distinct activity differences were observed in E. coli mutant strains ΔtolC, D22, ΔacrB and BL21(DE3)omp8. A comparison of the activity results of the E. coli mutants with respect to the known rules related to enhanced activity against Gram-negative bacteria revealed that applicability of the rules is not always ensured. Out of the four amino acids used in this study, glycine derivatives showed highest antibacterial activity, although still suffering from efflux issues. This journal is © The Royal Society of Chemistry.Entities:
Year: 2021 PMID: 34046630 PMCID: PMC8128065 DOI: 10.1039/d0md00409j
Source DB: PubMed Journal: RSC Med Chem ISSN: 2632-8682